The Cannabist Company Holdings Inc. (CBSTF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, The Cannabist Company Holdings Inc. (CBSTF) es una empresa del sector Healthcare valorada en 0. Calificado con 42/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 17 mar 2026The Cannabist Company Holdings Inc. (CBSTF) Resumen de Asistencia Médica y Tuberías
The Cannabist Company Holdings Inc. operates in the cannabis industry, cultivating, manufacturing, and distributing a variety of cannabis products. With licenses in 17 U.S. jurisdictions, the company offers flower, edibles, oils, and tablets under multiple brands, positioning itself in the competitive and evolving cannabis market.
Tesis de Inversión
The Cannabist Company Holdings Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's multi-state presence, with licenses in 17 jurisdictions, provides a foundation for growth as legalization expands. However, the company's negative P/E ratio of -0.07 and a negative profit margin of -51.2% indicate significant financial challenges. The gross margin of 29.5% suggests potential for improvement through operational efficiencies and strategic pricing. Key catalysts include potential regulatory changes and expansion into new markets. Investors should closely monitor the company's ability to achieve profitability and manage its operational costs. The company's beta of 0.75 suggests lower volatility compared to the overall market.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.01 billion indicates a small-cap company with potential for growth but also higher risk.
- Negative P/E ratio of -0.07 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Profit margin of -51.2% highlights significant operational challenges and the need for improved cost management.
- Gross margin of 29.5% suggests potential for profitability if operational efficiencies are improved.
- Licenses in 17 U.S. jurisdictions provide a substantial footprint for expansion as cannabis legalization progresses.
Competidores y Pares
Fortalezas
- Licenses in 17 U.S. jurisdictions.
- Diverse product portfolio.
- Established brand names.
- Vertical integration.
Debilidades
- Negative profit margin.
- High operational costs.
- Limited brand recognition compared to larger competitors.
- Dependence on regulatory changes.
Catalizadores
- Ongoing: Expansion into new markets as cannabis legalization progresses.
- Ongoing: Product innovation and diversification to meet evolving consumer preferences.
- Upcoming: Potential regulatory changes at the state or federal level.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
- Ongoing: Efforts to improve operational efficiency and reduce costs.
Riesgos
- Ongoing: Intense competition from other cannabis companies.
- Ongoing: Regulatory uncertainty and changing laws.
- Potential: Fluctuations in cannabis prices.
- Potential: Negative public perception of cannabis.
- Ongoing: Limited access to capital due to the nature of the business.
Oportunidades de crecimiento
- Expansion into New Markets: As cannabis legalization continues to spread across the United States and internationally, The Cannabist Company has the opportunity to expand its operations into new markets. Each new state or country that legalizes cannabis represents a potential revenue stream and growth opportunity. The timeline for this growth is dependent on the pace of legalization efforts, but the long-term trend is toward greater acceptance and accessibility. The company's existing licenses in 17 U.S. jurisdictions provide a strong foundation for further expansion.
- Product Innovation and Diversification: The Cannabist Company can drive growth by innovating and diversifying its product offerings. This includes developing new cannabis-infused products, exploring different consumption methods, and catering to specific consumer preferences. The market for cannabis-infused beverages, edibles, and wellness products is growing rapidly, presenting opportunities for the company to capture new market segments. The timeline for product development and launch is relatively short, allowing the company to quickly adapt to changing consumer demands.
- Strategic Partnerships and Acquisitions: The Cannabist Company can accelerate its growth through strategic partnerships and acquisitions. Collaborating with other companies in the cannabis industry, such as technology providers, distribution networks, or retail operators, can enhance its operational capabilities and market reach. Acquiring smaller companies with complementary products or technologies can also drive growth and expand its market share. The timeline for partnerships and acquisitions varies depending on the specific opportunities, but these strategies can provide significant growth potential in the medium to long term.
- Brand Building and Marketing: Investing in brand building and marketing is crucial for The Cannabist Company to differentiate itself from competitors and attract new customers. Developing strong brand recognition and loyalty can drive sales and increase market share. This includes creating compelling marketing campaigns, engaging with consumers through social media, and sponsoring events. The timeline for brand building is ongoing, requiring consistent effort and investment over the long term. A strong brand can command premium pricing and create a sustainable competitive advantage.
- Operational Efficiency and Cost Optimization: Improving operational efficiency and optimizing costs can significantly enhance The Cannabist Company's profitability and competitiveness. This includes streamlining its cultivation and manufacturing processes, reducing waste, and optimizing its supply chain. Implementing technology solutions, such as automation and data analytics, can also drive efficiency and reduce costs. The timeline for operational improvements is ongoing, requiring continuous monitoring and optimization. Increased efficiency can lead to higher gross margins and improved financial performance.
Oportunidades
- Expansion into new markets as legalization progresses.
- Product innovation and diversification.
- Strategic partnerships and acquisitions.
- Increasing demand for cannabis products.
Amenazas
- Intense competition.
- Regulatory uncertainty.
- Fluctuations in cannabis prices.
- Negative public perception of cannabis.
Ventajas competitivas
- Licenses: Holding licenses in 17 U.S. jurisdictions creates a barrier to entry.
- Brand Portfolio: A diverse portfolio of brands caters to different consumer segments.
- Vertical Integration: Controlling the cultivation, manufacturing, and distribution processes provides greater control over the supply chain and product quality.
Acerca de CBSTF
The Cannabist Company Holdings Inc., formerly known as Columbia Care Inc., was founded in 2012 and rebranded in September 2023. Headquartered in New York City, the company operates in the cannabis industry, focusing on the cultivation, manufacturing, and distribution of cannabis products and related services. The company's product offerings include flower, edibles, oils, and tablets, marketed under brand names such as Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. The Cannabist Company holds licenses in 17 jurisdictions within the United States, allowing it to operate across multiple states. This multi-state presence is crucial in the fragmented legal landscape of the cannabis industry in the U.S. The company aims to cater to a broad spectrum of consumer preferences through its diverse product portfolio. By offering a range of consumption methods and product types, The Cannabist Company seeks to capture different segments of the cannabis market. The company's strategic focus includes expanding its brand presence and optimizing its operational efficiency within existing markets. The Cannabist Company navigates the complex regulatory environment of the cannabis industry to establish a strong foothold in key markets.
Qué hacen
- Cultivates cannabis plants in licensed facilities.
- Manufactures a variety of cannabis products, including flower, edibles, oils, and tablets.
- Distributes cannabis products through its own retail locations and wholesale channels.
- Markets its products under various brand names, such as Seed & Strain, Triple Seven, and Hedy.
- Holds licenses to operate in 17 jurisdictions in the United States.
- Provides cannabis-related services to consumers and businesses.
Modelo de Negocio
- Cultivation and Manufacturing: The company grows cannabis and manufactures various cannabis products.
- Retail Sales: The company sells its products directly to consumers through its own retail stores.
- Wholesale Distribution: The company distributes its products to other retailers and dispensaries.
Contexto de la Industria
The Cannabist Company operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and market expansion. The U.S. cannabis market is projected to reach significant growth in the coming years, driven by both medical and recreational use. The competitive landscape includes both large multi-state operators and smaller regional players. Companies like CANSF (Columbia Care Cannabis Corp), CNTMF (Cresco Labs Inc.), DXBRF (Dixie Brands Inc.), ELIXF (Elixinol Wellness Limited), and GHBWF (Greenlane Holdings Inc.) represent key competitors, each vying for market share through different strategies, such as brand differentiation, geographic expansion, and product innovation. The industry faces regulatory hurdles and varying state laws, requiring companies to navigate a complex legal environment.
Clientes Clave
- Adult recreational cannabis users.
- Patients with medical cannabis prescriptions.
- Wholesale clients, including other dispensaries and retailers.
Finanzas
Gráfico e información
Precio de la acción de The Cannabist Company Holdings Inc. (CBSTF): Price data unavailable
Últimas noticias
-
The Cannabist Company Announces Strategic Transactions and Initiates Proceedings Under the CCAA
businesswire.com · 24 mar 2026
-
Canadian Investment Regulatory Organization Trading Halt - CBST
CNW Group · 24 mar 2026
-
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
businesswire.com · 17 mar 2026
-
Innovative Industrial Properties Resolves PharmaCann Litigation; Details Lease Agreements
MT Newswires · 16 mar 2026
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CBSTF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CBSTF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CBSTF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Últimas Noticias
The Cannabist Company Announces Strategic Transactions and Initiates Proceedings Under the CCAA
Canadian Investment Regulatory Organization Trading Halt - CBST
The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders
Innovative Industrial Properties Resolves PharmaCann Litigation; Details Lease Agreements
Liderazgo: David J. Hart
Unknown
Information on David J. Hart's background is not available in the provided context. Without additional data, it is impossible to provide details on his career history, education, or previous roles.
Historial: Information on David J. Hart's track record is not available in the provided context. Without additional data, it is impossible to provide details on his key achievements, strategic decisions, or company milestones under his leadership.
Información del mercado OTC de CBSTF
The OTC Other tier represents the lowest tier of the OTC market, indicating that The Cannabist Company Holdings Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in this tier often have limited operating history, may be thinly traded, and are subject to less stringent regulatory oversight. This tier is typically associated with higher risk and requires greater due diligence from investors compared to companies listed on major exchanges.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited liquidity due to low trading volume.
- Less stringent regulatory oversight compared to major exchanges.
- Higher price volatility.
- Potential for limited or delayed financial reporting.
- Increased risk of fraud or manipulation.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's risk factors and potential liabilities.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- The company has been in operation since 2012.
- The company holds licenses in 17 U.S. jurisdictions.
- The company has a diverse product portfolio.
- The company has a physical headquarters in New York City.
CBSTF Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar CBSTF?
The Cannabist Company Holdings Inc. (CBSTF) actualmente tiene una puntuación IA de 42/100, indicando puntuación baja. Fortaleza clave: Licenses in 17 U.S. jurisdictions.. Riesgo principal a monitorear: Ongoing: Intense competition from other cannabis companies.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CBSTF?
CBSTF actualmente puntúa 42/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CBSTF?
Los precios de CBSTF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CBSTF?
La cobertura de analistas para CBSTF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CBSTF?
Las categorías de riesgo para CBSTF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition from other cannabis companies.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CBSTF?
La relación P/E para CBSTF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CBSTF sobrevalorada o infravalorada?
Determinar si The Cannabist Company Holdings Inc. (CBSTF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CBSTF?
The Cannabist Company Holdings Inc. (CBSTF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available data and may be subject to change.
- Financial data may not be fully up-to-date due to the nature of the OTC listing.